GI
RCUS icon

GAMMA Investing’s Arcus Biosciences RCUS Stock Holding History

GAMMA Investing’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$122K Buy
3,966
+359
+10% +$8.87K ﹤0.01% 1660
2026
Q1 		$77.9K Buy
3,607
+377
+12% +$8.14K ﹤0.01% 1847
2025
Q4 		$77K Buy
3,230
+482
+18% +$9.83K ﹤0.01% 1768
2025
Q3 		$37.4K Buy
2,748
+1,021
+59% +$10.6K ﹤0.01% 2174
2025
Q2 		$14.1K Sell
1,727
-384
-18% -$3.28K ﹤0.01% 2641
2025
Q1 		$16.6K Buy
2,111
+1,006
+91% +$11.7K ﹤0.01% 2495
2024
Q4 		$16.5K Sell
1,105
-73
-6% -$1.19K ﹤0.01% 2371
2024
Q3 		$18K Buy
1,178
+12
+1% +$189 ﹤0.01% 2169
2024
Q2 		$17.8K Sell
1,166
-1,261
-52% -$20.4K ﹤0.01% 1927
2024
Q1 		$45.8K Buy
2,427
+826
+52% +$14.3K 0.01% 1102
2023
Q4 		$24.2K Buy
+1,601
New +$25.6K 0.01% 1365

Other funds holding RCUS

TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
SAM
Seelaus Asset Management Chatham, New Jersey $142M AUM 48.54% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return

GAMMA Investing's RCUS Position: Q2 2026 in Review

GAMMA Investing increased its Arcus Biosciences (RCUS) stake by 10% in Q2 2026, buying an estimated $8.87K and bringing the position to 3,966 shares worth $122K. The position accounts for ﹤0.01% of the portfolio, ranked #1660.

GAMMA Investing first reported a position in RCUS in Q4 2023 and has held it in 11 quarters since. 23 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.

  • GAMMA Investing held 3,966 shares of Arcus Biosciences worth $122K as of Q2 2026.
  • GAMMA Investing bought 359 Arcus Biosciences shares in Q2 2026, an estimated $8.87K.
  • Arcus Biosciences made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #1660 holding.
  • GAMMA Investing first reported a position in Arcus Biosciences in Q4 2023 and has held it in 11 quarters since.
  • 23 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.